Download Ch 35 BREAST CANCER

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Ch 35 BREAST CANCER
부산백병원 산부인과
R1 서 영 진




1/3 of all cancers in women
2nd only to lung cancer as the leading cause of
cancer deaths in women
Incidence: increased significantly
one in every eight women in U.S.A
But, mortality rate actually declined
-increased success in earlier diagnosis & treatment
PREDISPOSING FACTOR

25세 미만: less than 1%
30세 이후: a sharp increase
45세-50세: short plateau
이후: increases steadily with age
PREDISPOSING FACTOR

Family hystory
-only 20%: family hystory
-mother & sister : breast cancer after menopause
-> risk is not increased
bilateral premenopausally
-> at least 40%~50%
unilateral premenopausally
-> 30%
-inherited oncogenes: BRCA 1 (chromosome 17q 21)
BRCA 2 (chromosome 13q 12-13)
PREDISPOSING FACTOR

Diet, obesity, and alcohol
- high-fat diet, obesity, alcohol :risk factor
- but, not clear
PREDISPOSING FACTOR

Reproductive and hormonal factors
- the risk of breast ca increases with the length of a
women’s reproductive phase
- menarche is lower
early menopause
artificial menopause (oophorectomy)
-> the risk is decreased
-> but, no clear association with irregularity &
duration of menses
-lactation does not affect the breast cancer
->but, risk is high : never pregnant > multiparous
-primigravida: older > younger (high incidence)
-although short-term estrogen treatment for
menopausal symptoms prebably does not increase
the risk of breast ca, prolonged use or higher dosages
of estrogen may increase the risk
-> low dose or combination with progestin
-> but, benbefits in preventing osteoporosis and
heart problem
HISTORY OF CANCER

Endometrial carcinoma, ovarian carcinoma, or colon
cancer has also been associated with an increased
risk of breast cancer
DIAGNOSIS



most commonly in the upper outer quadrant
(there is more beast tissue)
mammography and physical examination, the standard
screening modalities, are complementary
-10% to 50 % of cancers detectred mammographically
are not palpable, physocal exam detects 10% to 20%
of cancers not seen on mammography
All women unfergo screening mammography starting at
age 40, along with clinical or self breast examination
DIAGNOSIS




USG, MRI, CT, PET, sestamibiscans, serum blood
marker: be used only when indicated
palpation: easy- older, more fatty
Malignancy: thickening area amid normal nodulaity
skin dimpling
nipple retraction
skin erosion
clinically malignancy: 30~40% benign on histology
clinically benign: 20~25% malignant by biopsy
Biopsy techniques

Fine-needle aspiration cytology (FNA)
- 20- or 22- gauge needle
- a high level of diagnostic accuracy
:10-15% false negative
rare false positive
-negative FNA cytology results do not exclude
malignancy and usually are followes by excisional
biopsy or careful observation

Open biopsy
-FNA cytology has not been performed
the results are negative or eqivocal
1. the location of the mass confirmed
2. local anesthesia: skin, suncutaneous around mass
3. incision: directly over the mass (ellise-cosmetically)
paraareolar(near the nipple-areolar complex)
4. mass: gently grasped with Allis forcep or stay suture
5. the mass should be excised completely
6. adequate hemostasis
breast parenchyma : not reapproximated deeply
subcutaneous fat: with fine absorbable suture
skin: subcuticular suture and adhesive strips
usually a drain is not necessary

Mammographic localization biopsy
- biopsy of nonpalpable lesion
- mammographer : localization & a biologic dye
surgeon: review & excised

Stereotactic core biopsy
- localize abnormalities and perform needle biopsy
without surgery
PATHOLOGY AND
NATURAL HISTORY



Breast ca : in the intermediate-sized ducts or terminal
ducts and lobules
-the diagnosis of lobular and intraductal carcinoma is
based on histological appearance than site of origin
infiltrating ductal carcinoma: 60-70%
-mammographically, stellate density
-macroscopically, gritty and chalky
Medullary carcinoma
-a dence lymphocytic infiltration
-sloe growing, less aggressive malignancy



Mucinous (colloid) carcinoma : 5% of breast ca
-glossly, mucinous, gelatinous
Papillary carcinoma
-noninvasive ductal carcinoma
Tubualr carcinoma: 1% of breast ca
-better prognosis than infiltrating ductal carcinoma
rarely metastasize to axillary LN